Clinical Trial

A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Name: A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps — clinical trial record (NCT06639295)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study will evaluate the effect and safety of 611 in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-10-10.

Status change: Not Yet Recruiting → Active, Not Recruiting 2025-11-25

Trial Details

NCT Number	NCT06639295
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Sinusitis, Nasal Polyps
Enrollment	243 participants
Start Date	2024-11-22
Primary Completion	2025-12 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2025-12-03